• Respiratory Drugs, Prednisone
    Dosage form: Tablet
    Strength: 5mg, 20mg
    Indications/Special comments: Treatment of acute asthma in children
    Dosage Administration: < 1 year: acute asthma: 10mg orally every 12 hours. maintenance: 10mg orally every other day. 1 to 4 years: 20mg orally every 12 hours. maintenance: 20mg orally every other day. 5 to 12 years: 30mg orally every 12 hours; maintenance: 30mg orally every other day. >12 years: 40mg orally every 12 hours; maintenance: 40 mg orally every other day.
    View full drug info
  • Respiratory Drugs, Palivizumab
    Dosage form: Injection
    Strength: 50 mg/0.5ml
    Indications/Special comments: Respiratory syncytial virus prophylaxis: Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in paediatric patients at high risk of RSV disease. Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD), infants with a history of premature birth (=35 weeks gestational age), and children with haemodynamically significant congenital heart disease (CHD). The American Academy of Paediatrics (AAP, 2014) recommends RSV prophylaxis with palivizumab during RSV season for: Infants born at =28 weeks 6 days gestational age and <12 months at the start of RSV season; Infants <12 months of age with chronic lung disease (CLD) of prematurity; Infants =12 months of age with haemodynamically significant congenital heart disease (CHD); Infants and children <24 months of age with CLD of prematurity necessitating medical therapy (e.g., supplemental oxygen, bronchodilator, diuretic, or chronic steroid therapy) within 6 months prior to the beginning of RSV season). AAP also suggests that palivizumab prophylaxis may be considered in the following circumstances: Infants <12 months of age with congenital airway abnormality or neuromuscular disorder that decreases the ability to manage airway secretions; Infants <12 months of age with cystic fibrosis with clinical evidence of CLD and/or nutritional compromise; Children <24 months with cystic fibrosis with severe lung disease (previous hospitalization for pulmonary exacerbation in the first year of life or abnormalities on chest radiography or chest computed tomography that persist when stable) or weight for length less than the 10th percentile; Infants and children <24 months who are profoundly immunocompromised; Infants and children <24 months undergoing cardiac transplantation during RSV season; Limitations of use: Safety and efficacy have not been established for treatment of RSV disease.
    Dosage Administration: Prevention of RSV: IM: Infants and Children <2 years: 15mg/kg of body weight, monthly throughout RSV season (first dose administered prior to commencement of RSV season). Note: The American Academy of Pediatrics (AAP) recommends a maximum of 5 doses per season; if hospitalization occurs for breakthrough RSV infection, monthly prophylaxis should be discontinued for the remainder of that season (AAP, 2014). Cardiopulmonary bypass patients: IM: Administer an additional dose as soon as possible after cardiopulmonary bypass procedure or at the conclusion of extracorporeal membrane oxygenation, even if <1 month from previous dose (AAP, 2014). Special note: IM injection should (preferably) be in the anterolateral aspect of the thigh; gluteal muscle should not be used routinely because of risk of damage to the sciatic nerve. Injection volumes over 1 mL should be administered as divided doses.
    View full drug info
  • Otic Agents, Paradichlorobenzene –chlorbutol
    Dosage form: Ear Drop
    Strength: 10ml
    Indications/Special comments: Used to soften and help remove ear wax.
    Dosage Administration: See package insert
    View full drug info
  • Ophthalmic, Local Anaesthetic, Proparacaine
    Dosage form: Eye Drop
    Strength: 0.005
    Indications/Special comments: Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anaesthetic is indicated: corneal anaesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures
    Dosage Administration: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.Note: Proparacaine hydrochloride ophthalmic solution should be clear to straw-colour. If the solution becomes darker, discard the solution.
    View full drug info
  • Ophthalmic Anti-inflammatory Agents, Prednisolone Acetate
    Dosage form: Eye Drop
    Strength: 0.01
    Indications/Special comments: Corneal injury; ophthalmic inflammatory conditions
    Dosage Administration: Topical, to the conjunctiva: 1 or 2 drops of a 0.12 to 1% suspension two to four times a day.
    View full drug info
  • Neuromuscular Blockers, Pancuronium Bromide
    Dosage form: Injection
    Strength: 2mg/ml
    Indications/Special comments: Management of mechanically ventilated patients and used for surgery.
    Dosage Administration: IV: Adult: initially: 0.04 - 0.1mg/kg; further doses of 0.01 - 0.02 mg/kg may be given as required. In intensive care: 0.06mg/kg every 1 - 1.5 hours. Following administration of suxamethonium, dose should be reduced; 0.02 - 0.06mg/kg may be adequate for the initial dose. Child: over 2 months: 0.04 - 0.1mg/kg; increments of 0.01 - 0.02mg/kg if required. Neonates: 0.03 - 0.04mg/kg with increments of 0.01 - 0.02mg/kg if needed. Should be used with extreme caution.
    View full drug info
  • Mydriatics / Cycloplegics, Phenylephrine
    Dosage form: Eye Drop
    Strength: 2.5%, 10%.
    Indications/Special comments: Mydriasis, diagnostic aid and ophthalmic decongestion
    Dosage Administration: Adult: 1 drop of a 10% solution as required
    View full drug info
  • Miscellaneous Drugs, Pentoxyfylline
    Dosage form: Tablet
    Strength: 400 mg
    Indications/Special comments: Peripheral vascular disease. Venous leg ulcer (adjunct).
    Dosage Administration: Adult: 400mg 2 – 3 times a day.
    View full drug info
  • Keratolytics/Caustics and Antiacne Agents, Podophyllin Paint
    Dosage form: Solution
    Strength: 0.25
    Indications/Special comments: Topical treatment of benign growths including external genital and perianal warts, papillomas, fibroids.
    Dosage Administration: Apply drug to dry surface, use 1 drop at a time allowing drying between drops until area is covered; total volume should be limited to less than 0.5ml per treatment session.
    View full drug info
  • Keratolytics/Caustics and Antiacne Agents, Podoflox
    Dosage form: Cream
    Strength: 0.005
    Indications/Special comments: Condylomata acuminata affecting the penis or the female external genitalia
    Dosage Administration: Adult: Apply twice daily for 3 consecutive days; treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses; direct medical supervision for lesions greater than 4cm2.
    View full drug info